| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |